The CEO's $214K open-market purchase is a strong bullish signal for a $45M micro-cap. Monitor for upcoming catalysts (e.g., pipeline updates, partnership news) that may have prompted the buying. The 88% analyst bullish consensus supports the positive read-through.
Price Chart
Executive Summary
Two insiders at Grace Therapeutics, including the CEO and a 10% owner, made open-market purchases totaling $226K in a 7-day window. The CEO's $214K buy is a strong conviction signal, especially given the company's $45M market cap and 88% analyst bullishness. This cluster of buys is amplified by the cross-filing context, indicating informed buying ahead of potential catalysts.
Key Financial Metrics
Key Facts
- CEO Prashant Kohli purchased 100,000 shares at $2.14 for $214K in an open-market transaction on 2026-09-09.
- 10% owner Opaleye Management purchased 15,229 shares total ($31.9K) across two open-market buys on 2026-09-08 and 2026-09-09.
- Total insider buying in the cluster is $226K, representing approximately 0.5% of the $45M market cap.
- The cluster is amplified by cross-filing context (cluster-insider-trades + cluster-agreement-context, etc.), per actuarial verdicts.
Financial Impact
CEO and 10% owner purchased $226K in open-market shares, ~0.5% of market cap.
Risk Factors
- Micro-cap biotech with no revenue; stock is highly volatile and subject to binary pipeline events.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-GRCE-1789106844520 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 10, 2026 6w ago | Insider Cluster | $2.26 $2.22 | ▼ −1.77% | ▼ −2.62% | $1.93 (−14.60%) |
Aug 13, 2026 10w ago | 8-K | $2.07 $2.16 | ▲ +4.35% | ▲ +4.55% | $1.93 (−6.76%) |
Aug 13, 2026 10w ago | Press Release | $2.07 $2.16 | ▲ +4.35% | ▲ +4.55% | $1.93 (−6.76%) |
Aug 4, 2026 11w ago | Press Release | $2.14 $2.12 | ▼ −0.93% | ▼ −0.77% | $1.93 (−9.81%) |
Jul 28, 2026 12w ago | 8-K | $2.25 $2.08 | ▼ −7.56% | ▼ −6.02% | $1.93 (−14.22%) |
Jun 18, 2026 18w ago | 8-K | $2.38 $2.26 | ▼ −5.04% | ▼ −4.73% | $1.93 (−18.91%) |
Jun 18, 2026 18w ago | 8-K | $2.38 $2.26 | ▲ +5.04% | ▲ +4.73% | $1.93 (+18.91%) |
Jun 18, 2026 18w ago | Press Release | $2.38 $2.26 | ▲ +5.04% | ▲ +4.73% | $1.93 (+18.91%) |
Jun 5, 2026 20w ago | 8-K | $2.30 $2.33 | ▲ +1.30% | ▲ +1.60% | $1.93 (−16.09%) |
Apr 27, 2026 26w ago | 8-K | $2.16 $2.10 | ▲ +2.78% | ▲ +2.29% | $1.93 (+10.65%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers